Establishment Labs Holdings INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Establishment Labs Holdings Inc. announces its 2026 Annual Meeting of Shareholders, scheduled for May 22, 2026, to elect directors, approve executive compensation, and ratify auditor appointment.
NASDAQ
DEFA14A: Establishment Labs Holdings Inc. Announces Change in Auditor Ahead of 2025 Annual General Meeting
Establishment Labs Holdings Inc. supplements its proxy statement to reflect the engagement of CBIZ CPAs P.C. as the new independent registered public accounting firm following Marcum LLP's resignation.
NASDAQ
Establishment Labs Holdings Inc. has appointed Fillipo Peter Caldini, the interim CEO, as the permanent Chief Executive Officer and a Class II director, effective May 7, 2025, and May 24, 2025, respectively.
NASDAQ
Establishment Labs Holdings Inc. has filed a definitive proxy statement with the SEC.
NASDAQ
Establishment Labs Holdings Inc. will hold its 2025 Annual Meeting of Shareholders virtually on May 23, 2025, to vote on director elections, executive compensation, and the ratification of the company's accounting firm.
NASDAQ
Establishment Labs Holdings Inc. has filed a definitive proxy statement with the SEC, indicating upcoming shareholder meetings and voting matters.
NASDAQ
Establishment Labs Holdings Inc. will hold its 2024 annual meeting of shareholders on May 24, 2024, via live audio webcast.